Clinical trial Recruiting at 1 site Observational

Long-term follow-up of anxiety and depression in cancer patients

Official title: A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors

Run by Henan Cancer Hospital · NCT05596344 · Data updated 2026-11-12

This study is trying to see how anxiety and depression affect cancer patients over time and how it relates to their treatment and recovery.

More Depression trials

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorHenan Cancer Hospital
Government
Locations1 site (Zhengzhou, Henan)
StatusRecruiting
StartedMay 20, 2023
Main results expectedNovember 30, 2032
Study endsNovember 30, 2032
Registry record updatedNovember 13, 2023
Trial IDNCT05596344 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include men and women of all ages with a pathological diagnosis of malignant tumors who have been hospitalized at Henan Cancer Hospital.

Probably not a fit

Patients without a pathological report of malignancy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enroll 200 patients with malignant tumors at Henan Cancer Hospital to assess their levels of anxiety and depression over time. It will collect data on patients' basic information, treatment, and prognosis, utilizing the Hospital Anxiety and Depression Scale for evaluation. The study is designed to provide insights into the psychological impact of cancer on patients and how it correlates with their treatment outcomes.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the psychological challenges faced by cancer patients, leading to improved mental health support and treatment strategies.

How similar studies have gone: Other studies have shown success in understanding the psychological effects of cancer, indicating that this approach is supported by existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Men and women of all ages are welcome.
2. Pathological diagnosis of malignant tumor in our hospital.
3. Received at least one hospitalization at this hospital.
4. The expected survival time is greater than 1 year.

Exclusion Criteria:

1.There was no pathological report of malignancy.

Where it's running

  • Department of Bone and Soft Tissue ,Henan Cancer Hospital
    Zhengzhou, Henan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.